Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville GlobeNewswire - Tue Jun 17, 6:00AM CDT

OCX : 3.20 (+17.22%)
IMDX : 5.09 (-1.17%)
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology GlobeNewswire - Mon May 19, 3:05PM CDT

OCX : 3.20 (+17.22%)
OncoCyte: Q1 Earnings Snapshot AP - Mon May 12, 3:36PM CDT

OncoCyte: Q1 Earnings Snapshot

OCX : 3.20 (+17.22%)
Oncocyte Reports Q1 2025 Results and Business Progress GlobeNewswire - Mon May 12, 3:05PM CDT

OCX : 3.20 (+17.22%)
Oncocyte to Release First Quarter 2025 Results on May 12, 2025 GlobeNewswire - Wed May 7, 3:10PM CDT

OCX : 3.20 (+17.22%)
Best Momentum Stocks to Buy for May 6th
Best Momentum Stocks to Buy for May 6th Zacks Investment Research - Tue May 6, 10:14AM CDT

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and witnessed...

OCX : 3.20 (+17.22%)
BYRN : 19.01 (+0.05%)
MAIA : 1.3800 (+2.22%)
Oncocyte Provides Positive Update on Clinical Trial Progress GlobeNewswire - Wed Apr 30, 7:30AM CDT

OCX : 3.20 (+17.22%)
Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity GlobeNewswire - Tue Apr 29, 7:30AM CDT

OCX : 3.20 (+17.22%)
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference GlobeNewswire - Wed Apr 2, 7:45AM CDT

OCX : 3.20 (+17.22%)
OncoCyte: Q4 Earnings Snapshot AP - Mon Mar 24, 3:29PM CDT

OncoCyte: Q4 Earnings Snapshot

OCX : 3.20 (+17.22%)

Barchart Exclusives

Jamie Dimon Has Long Been Sounding the Economic Alarm. After the Fed’s Latest Rate Cut, Can You Still Bank on JPMorgan Stock? Barchart - Wed Dec 10, 8:10PM CST
A nearly 5% plunge in JPM shares on Tuesday is reason for caution with the leader of U.S. bank stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot